SCIENTIFIC HUB

Follow the evidence.

SCIENTIFIC LITERATURE · MED

Association of neurogenic orthostatic hypotension with cognitive decline in Parkinson's disease: a longitudinal cohort study.

Front Neurol · 2026-03-12

DOI: 10.3389/fneur.2026.1783953PMID: 41908284

Open accessresearch-article; Journal ArticleOriginal source ↗

Research overview

The text below is the source article’s original abstract under a verified reuse license. cc by

IntroductionNeurogenic orthostatic hypotension (nOH), a common non-motor feature of Parkinson's disease (PD), is defined as a sustained drop in blood pressure (BP) upon standing due to autonomic dysfunction. Although prior studies support an association between nOH and cognitive impairment, its longitudinal impact on cognitive decline in PD remains insufficiently explored. We aimed to determine to what extent baseline nOH is associated with an accelerated decline in global and exploratory domain-specific cognitive functions.MethodsA retrospective longitudinal cohort study was conducted using clinical data from patients with PD evaluated at the University of California San Diego movement disorders clinics between 2012 and 2024. Participants were classified as having nOH (nOH+) or without nOH (nOH-) based on initial orthostatic BP measurements (≥20 mmHg systolic BP and/or ≥10 mmHg diastolic BP reduction within 3 minutes of standing, with a blunted heart rate response [ΔHR/ΔSBP] ResultsPatients with nOH at the first visit showed faster decline in total MoCA scores (Interaction β = -0.57, SE = 0.15, p β = -0.15, SE = 0.05, p β = -0.13, SE = 0.04, p β = -0.18, SE = 0.06, p β = -0.16, SE = 0.05, p β = -0.14, SE = 0.05, p β = -0.17, SE = 0.06, p p > 0.6), indicating comparable rates of motor and nonmotor symptom progression between nOH+ and nOH- groups.DiscussionIn this single-center, real-world retrospective cohort, the presence of baseline nOH was associated with a more rapid decline in cognitive function. These findings highlight the potential importance of early autonomic assessment in PD and warrant further investigation in larger, multi-center studies to determine generalizability and to better understand the underlying mechanisms contributing to cognitive deterioration.

Scientific assessment

01

Research question

Assess the question within the original study’s scope.

02

Methods & sample

Check the source article for study design and sample details.

03

Key findings

An editorially approved findings summary is not yet published for this record.

04

Limitations

Generalizability, bias and clinical meaning require separate assessment.

Methods, samples and clinical conclusions are not inferred from bibliographic metadata.